Please login to the form below

Not currently logged in
Email:
Password:

apremilast

This page shows the latest apremilast news and features for those working in and with pharma, biotech and healthcare.

Allergan investors back AbbVie deal, but is a tax charge looming?

Allergan investors back AbbVie deal, but is a tax charge looming?

Therapeutics and Bristol-Myers Squibb’s forced divestiture of psoriasis drug Otezla (apremilast) in order to get its $74bn acquisition of Celgene over the line.

Latest news

More from news
Approximately 5 fully matching, plus 23 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Infographic: RA Perceptions

    The greatest levels of familiarity and interest were reported for novel small molecules such as Celgene’s Otezla (apremilast) and Pfizer’s Xeljanz (tofacitinib), which both offer a new oral alternative

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics